Parallax Volatility Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.1M | Sell |
3,428
-3,277
| -49% | -$3.32M | 0.01% | 697 |
|
|
2025
Q4 | $7.21M | Buy |
+6,705
| New | +$6.41M | 0.01% | 561 |
|
|
2025
Q3 | – | Sell |
-12,495
| Closed | -$9.3M | – | 1731 |
|
|
2025
Q2 | $9.74M | Sell |
12,495
-3,787
| -23% | -$2.94M | 0.02% | 438 |
|
|
2025
Q1 | $13.4M | Sell |
16,282
-57,126
| -78% | -$47.5M | 0.04% | 378 |
|
|
2024
Q4 | $56.7M | Buy |
73,408
+71,223
| +3,260% | +$59M | 0.11% | 142 |
|
|
2024
Q3 | $1.94M | Buy |
+2,185
| New | +$1.96M | ﹤0.01% | 1139 |
|
|
2023
Q4 | – | Sell |
-425
| Closed | -$248K | – | 2354 |
|
|
2023
Q3 | $228K | Buy |
+425
| New | +$219K | ﹤0.01% | 1791 |
|
|
2021
Q3 | – | Sell |
-135,225
| Closed | -$33.4M | – | 2044 |
|
|
2021
Q2 | $31M | Buy |
+135,225
| New | +$27.2M | 0.04% | 280 |
|
|
2021
Q1 | – | Sell |
-46,741
| Closed | -$7.89M | – | 1793 |
|
|
2020
Q4 | $7.89M | Buy |
46,741
+8,024
| +21% | +$1.2M | 0.01% | 800 |
|
|
2020
Q3 | $5.73M | Sell |
38,717
-25,362
| -40% | -$3.93M | ﹤0.01% | 1243 |
|
|
2020
Q2 | $10.5M | Buy |
64,079
+38,358
| +149% | +$5.89M | 0.01% | 762 |
|
|
2020
Q1 | $3.57M | Sell |
25,721
-117,377
| -82% | -$16.1M | ﹤0.01% | 1002 |
|
|
2019
Q4 | $18.8M | Buy |
143,098
+48,492
| +51% | +$5.62M | 0.02% | 441 |
|
|
2019
Q3 | $10.6M | Sell |
94,606
-31,951
| -25% | -$3.56M | 0.01% | 572 |
|
|
2019
Q2 | $14M | Buy |
126,557
+116,111
| +1,112% | +$13.7M | 0.02% | 441 |
|
|
2019
Q1 | $1.35M | Sell |
10,446
-55,887
| -84% | -$6.8M | ﹤0.01% | 1144 |
|
|
2018
Q4 | $7.68M | Buy |
66,333
+21,961
| +49% | +$2.45M | 0.01% | 593 |
|
|
2018
Q3 | $4.76M | Buy |
+44,372
| New | +$4.44M | 0.01% | 729 |
|
|
2018
Q2 | – | Sell |
-13,909
| Closed | -$1.08M | – | 2810 |
|
|
2018
Q1 | $1.08M | Sell |
13,909
-9,125
| -40% | -$735K | ﹤0.01% | 946 |
|
|
2017
Q4 | $1.95M | Buy |
23,034
+21,303
| +1,231% | +$1.81M | ﹤0.01% | 924 |
|
|
2017
Q3 | $148K | Sell |
1,731
-1,810
| -51% | -$148K | ﹤0.01% | 1530 |
|
|
2017
Q2 | $291K | Buy |
3,541
+2,819
| +390% | +$230K | ﹤0.01% | 1361 |
|
|
2017
Q1 | $61K | Sell |
722
-35,748
| -98% | -$2.86M | ﹤0.01% | 2509 |
|
|
2016
Q4 | $2.68M | Buy |
36,470
+20,529
| +129% | +$1.53M | 0.01% | 842 |
|
|
2016
Q3 | $1.28M | Buy |
+15,941
| New | +$1.28M | ﹤0.01% | 1159 |
|
|
2015
Q3 | – | Sell |
-20,778
| Closed | -$1.75M | – | 3605 |
|
|
2015
Q2 | $1.74M | Buy |
20,778
+15,313
| +280% | +$1.17M | ﹤0.01% | 1128 |
|
|
2015
Q1 | $397K | Sell |
5,465
-77,266
| -93% | -$5.5M | ﹤0.01% | 1677 |
|
|
2014
Q4 | $5.71M | Buy |
+82,731
| New | +$5.58M | 0.02% | 645 |
|
|
2014
Q3 | – | Sell |
-92,712
| Closed | -$5.87M | – | 4345 |
|
|
2014
Q2 | $5.76M | Sell |
92,712
-137,007
| -60% | -$8.17M | 0.02% | 443 |
|
|
2014
Q1 | $13.5M | Buy |
229,719
+146,167
| +175% | +$8.16M | 0.08% | 199 |
|
|
2013
Q4 | $4.26M | Sell |
83,552
-12,032
| -13% | -$603K | 0.02% | 469 |
|
|
2013
Q3 | $4.81M | Sell |
95,584
-26,289
| -22% | -$1.38M | 0.03% | 378 |
|
|
2013
Q2 | $5.99M | Buy |
+121,873
| New | +$6.63M | 0.03% | 371 |
|
Other funds holding LLY
VCM
VPM
Parallax Volatility Advisers's LLY Position: Q1 2026 in Review
Parallax Volatility Advisers reduced its Eli Lilly (LLY) stake by 49% in Q1 2026, selling an estimated $3.32M and leaving 3,428 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #697.
Parallax Volatility Advisers first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. The position peaked at $56.7M in Q4 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Parallax Volatility Advisers held 3,428 shares of Eli Lilly worth $3.1M as of Q1 2026.
- Parallax Volatility Advisers sold 3,277 Eli Lilly shares in Q1 2026, an estimated $3.32M.
- Eli Lilly made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #697 holding.
- Parallax Volatility Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
- Parallax Volatility Advisers's Eli Lilly position peaked at $56.7M in Q4 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.